Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin II Receptor Blockers: A Comparison of Outcomes in Patients With COVID-19

Affiliations

¹ Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute (A.K., J.S., M.K.C.), Cleveland Clinic, OH.
² Section of Cardiovascular Research, Heart, Vascular and Thoracic Department, Cleveland Clinic Akron General, OH (A.K.).
³ Center for Emergency Medicine-West, Cleveland Clinic Medina Hospital, Medina, OH (E.S.H.).
⁴ Department of Quantitative Health Sciences, Lerner Research Institute (A.S.N., A.M.), Cleveland Clinic, OH.
⁵ Department of Internal Medicine, Cleveland Clinic Foundation, OH (V.J.).
⁶ Department of Nephrology and Hypertension (G.T.), Cleveland Clinic, OH.
⁷ Department of Nephrology and Hypertension, Cleveland Clinic Florida, Weston, FL (S.K.G.).
⁸ Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute (S.S.K., M.K.C.), Cleveland Clinic, OH.
⁹ Cleveland Clinic Foundation, OH (L.J.).
¹⁰ Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University (J.B.Y., N.M.), Cleveland Clinic, OH.
¹¹ Department of Thoracic and Cardiovascular Surgery, Heart, Vascular and Thoracic Institute (L.G.S.), Cleveland Clinic, OH.

Comparative Study

Ankur Kalra et al. Circ Cardiovasc Qual Outcomes. 2020 Oct.

. 2020 Oct;13(10):e007115.

doi: 10.1161/CIRCOUTCOMES.120.007115. Epub 2020 Aug 28.

¹ Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute (A.K., J.S., M.K.C.), Cleveland Clinic, OH.
² Section of Cardiovascular Research, Heart, Vascular and Thoracic Department, Cleveland Clinic Akron General, OH (A.K.).
³ Center for Emergency Medicine-West, Cleveland Clinic Medina Hospital, Medina, OH (E.S.H.).
⁴ Department of Quantitative Health Sciences, Lerner Research Institute (A.S.N., A.M.), Cleveland Clinic, OH.
⁵ Department of Internal Medicine, Cleveland Clinic Foundation, OH (V.J.).
⁶ Department of Nephrology and Hypertension (G.T.), Cleveland Clinic, OH.
⁷ Department of Nephrology and Hypertension, Cleveland Clinic Florida, Weston, FL (S.K.G.).
⁸ Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute (S.S.K., M.K.C.), Cleveland Clinic, OH.
⁹ Cleveland Clinic Foundation, OH (L.J.).
¹⁰ Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University (J.B.Y., N.M.), Cleveland Clinic, OH.
¹¹ Department of Thoracic and Cardiovascular Surgery, Heart, Vascular and Thoracic Institute (L.G.S.), Cleveland Clinic, OH.

No abstract available

Keywords: COVID-19; mechanical ventilation; pandemic; propensity score; upregulation.

Figures

1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. - PMC - PubMed
1. Gallagher PE, Ferrario CM, Tallant EA. Regulation of ACE2 in cardiac myocytes and fibroblasts. Am J Physiol Heart Circ Physiol. 2008;295:H2373–2379. - PMC - PubMed
1. Hamming I, van Goor H, Turner AJ, Rushworth CA, Michaud AA, Corvol P, Navis G. Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats. Exp Physiol. 2008;93:631–638. - PubMed
1. Mehta N, Kalra A, Nowacki AS, Anjewierden S, Han Z, Bhat P, Carmona-Rubio AE, Jacob M, Procop GW, Harrington S, Milinovich A, Svensson LG, Jehi L, Young JB, Chung MK. Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020. doi: 10.1001/jamacardio.2020.1855 - DOI - PMC - PubMed
1. Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19. N Engl J Med. 2020;382:2431–2440. - PMC - PubMed